↓ Skip to main content

UGT1A1 polymorphisms in cancer: impact on irinotecan treatment

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, February 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

twitter
3 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
88 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
UGT1A1 polymorphisms in cancer: impact on irinotecan treatment
Published in
Pharmacogenomics and Personalized Medicine, February 2017
DOI 10.2147/pgpm.s108656
Pubmed ID
Authors

Masashi Takano, Toru Sugiyama

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 114 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 13%
Researcher 13 11%
Student > Bachelor 13 11%
Student > Ph. D. Student 11 10%
Other 5 4%
Other 12 11%
Unknown 45 39%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 26 23%
Medicine and Dentistry 12 11%
Biochemistry, Genetics and Molecular Biology 10 9%
Agricultural and Biological Sciences 7 6%
Social Sciences 2 2%
Other 7 6%
Unknown 50 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2020.
All research outputs
#7,180,078
of 25,748,735 outputs
Outputs from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Outputs of similar age
#124,209
of 427,196 outputs
Outputs of similar age from Pharmacogenomics and Personalized Medicine
#1
of 1 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 4.5. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,196 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them